Washington, Sept. 29 -- Representative Mike Quigley issued the following press release:
Yesterday, the Senate passed the Access to Critical Therapies for ALS Reauthorization Act (ACT for ALS Reauthorization Act) of 2026 with bipartisan support. Led by Representatives Mike Quigley (IL-05) and Ken Calvert (CA-41) in the House and Senators Lisa Murkowski (R-AK) and Chris Coons (D-DE) in the Senate, the ACT for ALS Reauthorization Act will renew programs from the 2021 ACT for ALS, which advanced scientific understanding of neurodegenerative diseases and helped people living with ALS access promising new treatments.
"Since 2021, the ACT for ALS has helped thousands of Americans access the promising treatments and research they need," said Rep...